1例吉西他滨难治性胰腺癌对使用S-1的二线化疗有反应。 - Suppr

Suppr

超能文献

A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

作者信息

Morizane Chigusa

机构信息

Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Jpn J Clin Oncol. 2007 Dec;37(12):973. doi: 10.1093/jjco/hym146.

DOI:10.1093/jjco/hym146

PMID:18211987

Abstract

摘要

相似文献

A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

Jpn J Clin Oncol. 2007 Dec;37(12):973. doi: 10.1093/jjco/hym146.

Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.

Cancer Chemother Pharmacol. 2011 Sep;68(3):677-83. doi: 10.1007/s00280-010-1531-6. Epub 2010 Dec 5.

[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].

Gan To Kagaku Ryoho. 2015 May;42(5):633-5.

[A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].

Gan To Kagaku Ryoho. 2015 Nov;42(12):1582-4.

Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.

Jpn J Clin Oncol. 2010 Aug;40(8):774-80. doi: 10.1093/jjco/hyq059. Epub 2010 May 12.

S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.

Jpn J Clin Oncol. 2010 Jun;40(6):567-72. doi: 10.1093/jjco/hyq005. Epub 2010 Feb 26.

[The progress of chemotherapy for advanced pancreatic cancer].

Nihon Shokakibyo Gakkai Zasshi. 2015 Dec;112(12):2119-26. doi: 10.11405/nisshoshi.112.2119.

[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].

Gan To Kagaku Ryoho. 2008 Jun;35(6):1013-6.

[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].

Gan To Kagaku Ryoho. 2011 Jan;38(1):109-12.

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.

Ann Oncol. 2016 Mar;27(3):502-8. doi: 10.1093/annonc/mdv603. Epub 2015 Dec 17.

引用本文的文献

Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.

Oncol Lett. 2012 Jun;3(6):1314-1318. doi: 10.3892/ol.2012.637. Epub 2012 Mar 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

作者信息

Morizane Chigusa

机构信息

Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Jpn J Clin Oncol. 2007 Dec;37(12):973. doi: 10.1093/jjco/hym146.

DOI:10.1093/jjco/hym146

PMID:18211987

Abstract

摘要